SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-18-011665
Filing Date
2018-10-29
Accepted
2018-10-29 16:16:50
Documents
50
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT vtgn_10q.htm 10-Q 1300978
2 LICENSE AGREEMENT ex10-3.htm EX-10.3 187823
3 FORM OF PRIVATE PLACEMENT SUBSCRIPTION AGREEMENT ex10-4.htm EX-10.4 99185
4 FORM OF PRIVATE PLACEMENT WARRANT ex10-5.htm EX-10.5 52777
5 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-1.htm EX-31.1 15611
6 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-2.htm EX-31.2 16079
7 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE ex-32.htm EX-32 6973
  Complete submission text file 0001654954-18-011665.txt   3345947

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT vtgn-20180930.xml EX-101.INS 401075
9 XBRL TAXONOMY EXTENSION SCHEMA vtgn-20180930.xsd EX-101.SCH 25863
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtgn-20180930_cal.xml EX-101.CAL 35528
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtgn-20180930_def.xml EX-101.DEF 76495
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtgn-20180930_lab.xml EX-101.LAB 145904
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtgn-20180930_pre.xml EX-101.PRE 123425
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37761 | Film No.: 181144391
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences